Cargando…
Linking unfolded protein response to ovarian cancer cell fusion
BACKGROUND: Polyploid giant cancer cells (PGCCs) have been observed in epithelial ovarian tumors. They can resist antimitotic drugs, thus participating in tumor maintenance and recurrence. Although their origin remains unclear, PGCC formation seems to be enhanced by conditions that trigger the unfol...
Autores principales: | Yart, Lucile, Bastida-Ruiz, Daniel, Allard, Mathilde, Dietrich, Pierre-Yves, Petignat, Patrick, Cohen, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172076/ https://www.ncbi.nlm.nih.gov/pubmed/35672715 http://dx.doi.org/10.1186/s12885-022-09648-4 |
Ejemplares similares
-
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
por: Fraguas-Sánchez, Ana I., et al.
Publicado: (2020) -
The fine-tuning of endoplasmic reticulum stress response and autophagy activation during trophoblast syncytialization
por: Bastida-Ruiz, Daniel, et al.
Publicado: (2019) -
UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
por: Husein, Melisa, et al.
Publicado: (2023) -
The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014) -
GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach
por: Delie, Florence, et al.
Publicado: (2012)